Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for prevention of taxane-induced peripheral neuropathy
IRCT20090613002027N20Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chemotherapy-induced peripheral neuropathy (CIPN) comparing N-acetylcysteine arm with Placebo arm (2 arms). Primary endpoints: severity of peripheral neuropathy, pain intensity and 2 more. Started Jun 2023; status: completed.
02
Drugs
acetylcysteine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on IRCT20090613002027N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090613002027N20.